These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7518601)

  • 21. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
    Wynick D; Smith DM; Ghatei M; Akinsanya K; Bhogal R; Purkiss P; Byfield P; Yanaihara N; Bloom SR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4231-5. PubMed ID: 7683428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisecretory effects of galanin and its putative antagonists M15, M35 and C7 in the rat stomach.
    Kisfalvi I; Burghardt B; Bálint A; Zelles T; Vizi ES; Varga G
    J Physiol Paris; 2000; 94(1):37-42. PubMed ID: 10761687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galanin stimulates striatal acetylcholine release via a mechanism unrelated to cholinergic receptor stimulation.
    Pramanik A; Ogren SO
    Regul Pept; 1993 Jun; 45(3):353-62. PubMed ID: 7688904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of galanin and the galanin receptor antagonist galantide on plasma catecholamine levels during a psychosocial stress stimulus in rats.
    Ceresini G; Sgoifo A; Freddi M; Musso E; Parmigiani S; Del Rio G; Valenti G
    Neuroendocrinology; 1998 Jan; 67(1):67-72. PubMed ID: 9485171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galanin receptor antagonists M40 and C7 block galanin-induced feeding.
    Crawley JN; Robinson JK; Langel U; Bartfai T
    Brain Res; 1993 Jan; 600(2):268-72. PubMed ID: 7679604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus.
    Potter EK
    J Auton Nerv Syst; 1987 Nov; 21(1):87-90. PubMed ID: 3440821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw.
    Xu XJ; Hao JX; Wiesenfeld-Hallin Z; Håkanson R; Folkers K; Hökfelt T
    Neuroscience; 1991; 42(3):731-7. PubMed ID: 1720225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
    Potter EK; McCloskey DI
    Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus.
    Horvath TL; Naftolin F; Leranth C; Sahu A; Kalra SP
    Endocrinology; 1996 Jul; 137(7):3069-78. PubMed ID: 8770933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat.
    Corwin RL; Robinson JK; Crawley JN
    Eur J Neurosci; 1993 Nov; 5(11):1528-33. PubMed ID: 7506975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization by neuropeptide Y of effects of sympathetic stimulation on cardiac vagal action in anaesthetised dogs.
    Moriarty M; Potter EK; McCloskey DI
    J Auton Nerv Syst; 1993 Oct; 45(1):21-8. PubMed ID: 8227962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.
    Lindskog S; Ahrén B; Land T; Langel U; Bartfai T
    Eur J Pharmacol; 1992 Jan; 210(2):183-8. PubMed ID: 1376272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galanin receptor antagonists decrease fat preference in Brattleboro rat.
    Odorizzi M; Fernette B; Angel E; Burlet C; Tankosic P; Burlet A
    Neuropharmacology; 2002 Jan; 42(1):134-41. PubMed ID: 11750923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic responses to stimulation of the cardiac autonomic nerves in the anaesthetized cat with closed chest.
    Barnes RJ; Bower EA; Rink TJ
    J Physiol; 1980 Feb; 299():55-73. PubMed ID: 7381778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of galanin and galanin antagonists on peristalsis in esophageal smooth muscle in the opossum.
    Yamato S; Hirano I; Goyal RK
    Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G719-25. PubMed ID: 11005758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.
    Wodowska J; Ciosek J
    Neuropeptides; 2014 Dec; 48(6):387-97. PubMed ID: 25464889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.
    Potter E
    Neurosci Lett; 1987 Dec; 83(1-2):101-6. PubMed ID: 3441289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. An in situ hybridization and immunohistochemistry study.
    Landry M; Roche D; Calas A
    Neuroendocrinology; 1995 Apr; 61(4):393-404. PubMed ID: 7540263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The galanin antagonist, M-15, inhibits growth hormone release in rats.
    Gabriel SM; Rivkin A; Mercado J
    Peptides; 1993; 14(3):633-6. PubMed ID: 7687353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflex circulatory changes due to the afferent stimulation of cat pericoronary nerve.
    Shimizu T; Peterson DF; Bishop VS
    Am J Physiol; 1978 Dec; 235(6):H759-66. PubMed ID: 736163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.